AUM$960.7M
Expense Ratio0.40%
NAV$29.14
Holdings66
InceptionNov 1, 2006
Price Chart
Key Statistics
Previous Close
—Day Range
N/A52-Week Range
N/AAvg Volume
8.1KDividend Yield
0.08%Expense Ratio
0.40%AUM
$960.7MShares Outstanding
—ETF Grades
?Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 99.98% |
| Cash & Others | 0.02% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 95.53% |
| Ireland | 2.93% |
| Other | 1.54% |
Fund Information
- Issuer
- Invesco
- Category
- Healthcare
- Types
- Equal WeightS&P 500
- Inception Date
- Nov 1, 2006
- Description
- The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of all of the components of the S&P 500® Health Care Index, an index that contains the common stocks of all companies included in the S&P 500® Index that are classified as members of the health care sector, as defined according to the Global Industry Classification Standard (GICS).
Similar ETFs
The Invesco S&P 500 Equal Weight Health Care ETF (RYH) is an exchange-traded fund issued by Invesco that launched on Nov 1, 2006. It currently manages $960.7M in assets under management. The fund charges an expense ratio of 0.40%. The fund holds 66 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 21.4% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | MRNA | Moderna Inc | 3.25% | 423,914 | $23.7M |
| 2 | DVA | DaVita Inc | 2.20% | 103,653 | $16.0M |
| 3 | VTRS | Viatris Inc | 2.03% | 1,061,136 | $14.8M |
| 4 | GILD | Gilead Sciences Inc | 2.03% | 101,426 | $14.8M |
| 5 | AMGN | Amgen Inc | 2.02% | 39,019 | $14.7M |
| 6 | MRK | Merck & Co Inc | 2.01% | 126,088 | $14.7M |
| 7 | JNJ | Johnson & Johnson | 1.98% | 59,580 | $14.5M |
| 8 | BMY | Bristol-Myers Squibb Co | 1.97% | 240,363 | $14.4M |
| 9 | MCK | McKesson Corp | 1.94% | 15,143 | $14.1M |
| 10 | HCA | HCA Healthcare Inc | 1.93% | 26,249 | $14.1M |
| 11 | DGX | Quest Diagnostics Inc | 1.88% | 68,531 | $13.7M |
| 12 | VRTX | Vertex Pharmaceuticals Inc | 1.87% | 27,680 | $13.6M |
| 13 | CAH | Cardinal Health Inc | 1.83% | 62,087 | $13.4M |
| 14 | BIIB | Biogen Inc | 1.81% | 69,325 | $13.2M |
| 15 | REGN | Regeneron Pharmaceuticals Inc | 1.80% | 16,946 | $13.1M |
Page 1 of 2
Detailed Returns
| Period | Return | ETF | Cat. Avg | vs Avg |
|---|---|---|---|---|
| 1D | — | — | ||
| 1W | — | — | ||
| 1M | — | — | ||
| 3M | — | — | ||
| 6M | — | — | ||
| YTD | — | — | ||
| 1Y | — | — | ||
| 3Y | +1.40% | — | ||
| 5Y | +7.92% | — |
Moving Averages
20-Day MA
—
50-Day MA
—
200-Day MA
—
Price with Moving Averages
Support & Resistance
52-Week High
—
Current Price
$287.06
52-Week Low
—
Current Yield
0.08%
Annual Dividend
$0.3848
Frequency
4x/year
Last Ex-Date
Sep 19, 2008
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Sep 19, 2008 | $0.0344 | Sep 30, 2008 |
| Jun 20, 2008 | $0.2834 | Jun 30, 2008 |
| Mar 20, 2008 | $0.0351 | Mar 31, 2008 |
| Dec 21, 2007 | $0.0319 | Dec 31, 2007 |
| Sep 21, 2007 | $0.0251 | Sep 28, 2007 |
| Jun 15, 2007 | $0.0271 | Jun 29, 2007 |
| Mar 16, 2007 | $0.0255 | Mar 30, 2007 |
Dividend Payments Over Time
Category Comparison
| Metric | RYH | Healthcare(222 ETFs) | Equal Weight(109 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.40% | 0.59% | 0.68% |
| AUM | $960.7M | $1.25B | $1.49B |
| Dividend Yield | 0.08% | 3.24% | 2.88% |
| Avg Volume | 8.1K | 588.6K | 852.1K |
| Holdings | 66 | 172 | 120 |
| Performance | |||
| 1-Month Return | — | -3.19% | -2.21% |
| 6-Month Return | — | +5.94% | +5.16% |
| YTD Return | — | -1.42% | +1.24% |
| 1-Year Return | — | +17.48% | +21.07% |
Compare with Another ETF
Search for an ETF to compare with RYH: